Paul Moraviec is Chief Executive Officer of ConvaTec. He joined the company in 2009 as President of Europe, Middle East and Africa (EMEA), which is ConvaTec's largest geographic region. Paul has a track record of driving growth in major global healthcare companies across a number of medical device specialties including orthopedics, neurosurgery, diabetes and general surgery. He has held international leadership roles with Johnson & Johnson, Abbott Laboratories and Bausch and Lomb, as well as CEO roles with two early-stage venture capital funded companies. Paul holds a Master's degree in Marketing from Kingston University Business School in the UK.
Nigel Clerkin is the Chief Financial Officer of ConvaTec. He was previously Executive Vice President and Chief Financial Officer of Elan Corporation, a Dublin-based biotechnology company. He was part of a senior team that built significant shareholder value at Elan, culminating in its sale to Perrigo, a pharmaceutical manufacturer, in December 2013. Nigel joined Elan in 1998 and held a series of roles in strategic planning and finance prior to being named CFO in 2011. Earlier in his career, Nigel was an auditor with KPMG. He holds Bachelor’s and Master’s degrees in accounting from Queens University, Belfast, and is a fellow of Chartered Accountants Ireland.
Symeria Hudson is President, Global Franchises and Innovation at ConvaTec. Ms. Hudson joined ConvaTec in 2016 from Baxter, Inc., where she was Global Franchise Head, Renal Home Therapies. Prior to joining Baxter, she held a number of senior roles at Hospira, helping to transform the company following its spin-off from Abbott. She began her career in accounting, moving into marketing and management, with a number of leading FMCG and business services companies. Ms. Hudson holds a Bachelor of Sciences degree in Accounting from Alabama A&M University and an MBA from Harvard Business School.
Tim Moran is President of the Americas at ConvaTec. He joined the company in 2015 from Medtronic, where he was Vice President and General Manager of the Patient Care and Safety Division. After joining Kendall in 1997, Tim was promoted to roles of increasing responsibility in sales, marketing and general management within Tyco Healthcare, Covidien and Medtronic. Prior to joining Kendall, he held sales positions with a number of medical and communications technology firms in the US. Tim holds a Bachelor of Arts degree in Organizational Communication from the State University of New York at Geneseo.
Antonio La Regina is President of ConvaTec's Europe, Middle East and Africa (EMEA) region. He joined ConvaTec in 2006 as Managing Director for Italy. In 2011, he was appointed Vice President and General Manager of United Kingdom/Ireland and Italy/Greece. Most recently, he served as Vice President and General Manager for western and southern EMEA. Prior to joining ConvaTec, Antonio worked for Zambon Group and Bristol-Myers Squibb in both Italy and France in a variety of commercial and functional roles. Antonio holds a degree in Biology, a Ph.D in Pharmacology and completed the General Management Program at CEDEP-INSEAD Business School in Fontainebleau in France. He is a member of the Eucomed Board of Directors.
John M. Lindskog is President, B2B and Infusion Devices for ConvaTec. He joined the company in 2008 when, as General Manager of Unomedical’s Infusion Device business unit, he helped lead the integration of Unomedical into ConvaTec. His 25 years of experience in the infusion devices industry began at Pharma-Plast, which later merged with Maersk Medical and became Unomedical. John holds a Bachelor’s degree in Business Administration through the internal academy at the East Asiatic Company in Denmark and a Graduate certificate in Business Administration from Copenhagen Business School.
George Poole is President of ConvaTec's Asia Pacific region. He joined ConvaTec in 2015 from Medtronic, where he spent 14 years in leadership roles in commercial, marketing, operations and general management. For the last five years, George was a key member of Medtronic’s Asia Pacific management team, most recently serving as Vice President/Managing Director, Southeast Asia. Prior to Medtronic, he served in sales positions with Welch Allyn and Olympus America. George holds a Bachelor of Science degree in Economics from the State University of New York at Cortland.
Michael Sgrignari is Executive Vice President of Operations at ConvaTec. He joined the company in 2015 from Medtronic's Covidien group, where we was Senior Vice President of Quality and Operations. Mike joined Covidien’s predecessor company, Tyco Healthcare's U.S. Surgical Division, in 1991. He advanced through roles of increasing responsibility, and in 2007, as VP of Global Operations for Tyco Healthcare, he led the operations planning in the spin-off to form Covidien. Mike holds a Bachelor of Science degree in Manufacturing Engineering from Boston University.
Marc Reuss is Executive Vice President of Human Resources at ConvaTec. He joined the company in 2015 from Novartis, where he was Global Head of Human Resources at the Vaccines and Diagnostics division, and, most recently, at Sandoz, Novartis' large generics division. Previously, Marc spent eight years with Boston Scientific, serving in senior international Human Resources roles, and began his career at a number of leading aerospace, financial services and high-technology companies. Marc holds a Bachelor of Arts degree in Psychology from Potsdam College in New York state and a Masters degree in Human Resources from Emmanuel College in Boston.
Adam Deutsch is Executive Vice President and General Counsel of ConvaTec. He joined the company in 2014 from Biomet, Inc., a leading global medical device company. His roles included Corporate Vice President and Associate General Counsel – Litigation, Investigations & Risk Management, as well as Chief Compliance Officer. Prior to joining Biomet, Adam was a partner and associate with prominent law firms based in Chicago. He holds a Bachelor of Arts degree from Rutgers University and a Juris Doctor degree from New York University School of Law.
Robert Steele is Executive Vice President of Quality, Regulatory and Clinical Affairs at ConvaTec. He joined the company in 2014 from Stryker. His most recent role was Vice President of Regulatory Affairs, Quality Assurance and Clinical. Prior to Stryker, Robert held a variety of roles with medical technologies company KCI, including Vice President of Global Quality. He began his career as an engineer working at medical device manufacturing companies in the UK. Robert holds a Bachelor of Arts degree in Electro Mechanical Engineering from Open University, as well as two National Certificates in Mechanical Engineering and one in Electronics Engineering. He is a Chartered Engineer and Chartered Quality professional.
Douglas LeFort is Senior Vice President of Corporate Development at ConvaTec. He joined the company in 2011 from Freehand Surgical Ltd., where he was CEO from 2009 to 2011. Prior to joining Freehand Surgical, he held leadership positions with Abbott Laboratories Diabetes Care Division, Chiron Corporation and SC Johnson Inc. Douglas holds an MBA from Henley Management College in the UK.
AQUACEL® Ag Dressing is not a drug • In all of our silver products, the anti-microbial activity occurs within the dressing. The correlation between in vitro testing and clinical effectiveness has not been evaluated.
Having trouble signing in?
You are leaving convatec.com
You are being redirected to another ConvaTec website